# Johns Hopkins Technology Ventures

Johns Hopkins Technology Ventures is a Venture Capital based in Baltimore, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Baltimore, United States
- **Region:** North America
- **Address:** Baltimore, MD, United States
- **Founded:** 2014
- **Assets under management:** Undisclosed
- **Website:** ventures.jhu.edu
- **LinkedIn:** https://www.linkedin.com/company/johns-hopkins-technology-transfer

## Regulatory record

- **Reports private funds:** No

## About

Johns Hopkins Technology Ventures is a US-based investment company headquartered in Baltimore. It focuses on a Venture Capital strategy.

## Sectors

- Life Sciences
- Digital Health
- Enterprise Software
- AI/ML
- Medical Devices

## People

- Christy Wyskiel — Executive Director and Senior Advisor to the President

## Questions

### Who runs investment decisions at Johns Hopkins Technology Ventures?

Executive Director Christy Wyskiel oversees the entire commercialization pipeline, reporting directly to the university president. A specialized licensing and ventures team, drawn from technology-transfer professionals with deep bench expertise in life sciences and engineering, manages individual deal diligence and startup formation. Investment allocations from the university's proof-of-concept funds are approved internally through a faculty-led review committee rather than a traditional investment committee model.

### How does JHTV source its deal flow?

All deal flow originates inside Johns Hopkins University. Faculty, postdocs, and graduate students disclose roughly 500 inventions annually through the technology-transfer office. JHTV then triages these disclosures, filing on the most commercially promising. Because Hopkins spends over $3.4 billion on research each year, the raw discovery pipeline is the deepest in American academia, and JHTV enjoys effectively exclusive first look at any patentable asset developed with university resources.

### What investment stages does JHTV target?

JHTV focuses exclusively on the earliest stage: proof-of-concept, pre-seed, and seed. Its vehicles, including the Louis B. Thalheimer Fund, bridge the gap between NIH or NSF research funding and a startup's first institutional venture round. JHTV rarely leads later-stage rounds but often retains equity stakes that carry into Series A and B financings led by external syndicates.

### Does JHTV participate in fund commitments or only direct deals?

Only direct deals. JHTV puts capital directly into startup spinouts and occasionally forms strategic licensing partnerships with established companies. It does not commit to external venture funds as an LP, which keeps the entire investment operation tightly aligned to Hopkins-originated intellectual property.

### Which sectors does JHTV explicitly prioritize?

The portfolio concentrates on life sciences — including therapeutics, diagnostics, and medical devices — and related health-adjacent areas such as digital health and healthcare IT. A smaller but active allocation covers engineering and enterprise software. JHTV generally does not invest in consumer internet, fintech, or companies without a clear lineage to a Hopkins lab discovery.

## Related profiles

- [John Fogwell & Associates](https://altss.com/profile/john-fogwell-associates)
- [Johnson & Johnson Impact Ventures](https://altss.com/profile/johnson-johnson-impact-ventures)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/johns-hopkins-technology-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology